16
Apr
Interview with Lisa McLaughlin of Workit Health
Q: What need is Workit Health addressing? Drug overdoses killed more Americans last year than were lost during the entire Vietnam War (69,000)....
16
Apr
Interview with Olivier Elemento of Weill Cornell Medicine
Q: What research are you or your lab focusing on and why, and what problem(s) are you trying to solve? I direct the Englander Institute for Precision Medicine, an Institute that focuses on using genomics and informatics to make medicine more individualized. ...
16
Apr
Interview with Dr. Dunnenberger of NorthShore University HealthSystem
Q: What patient population is NorthShore University HealthSystem serving and which services are you specializing in? NorthShore is a four hospital community health system with over 100 outpatient medical offices. ...
14
Apr
How Artificial Intelligence (AI) Will Potentiate Individualized Medicine, Q&A with Eric Topol
We had the chance to sit down with Dr. Topol to hear his thoughts on big data, digital health, sensors, and artificial intelligence, some of the newest precision medicine technologies....
10
Apr
Interview with Jennifer Kloke of Ayasdi
Q: What need is Ayasdi addressing? Ayasdi is pioneering the application of AI to value-based care by targeting two of the most complex problems in healthcare: population risk stratification and clinical variation management. ...
08
Apr
Q&A with Eric Topol, Executive Vice President, Scripps Research Institute
Dr. Eric Topol, voted by Modern Healthcare as the most influential physician executive in the United States, shared his thoughts on why people should own and control their own data....
26
Mar
CMS to Approve Coverage of NGS-based Cancer Testing | Big Pharma’s Response & The effect on PM
Why this is a Big Deal? As we know, private insurers follow suit once Medicare makes a decision such as this. This portends well for genetic testing to become routine standard of care for patients with advanced cancers. ...
23
Mar
Q&A with Mickey Kertesz, Chief Executive Officer, Karius
Q: Tell us a little bit about Karius – what problem(s)/need(s) are you trying to address and what technology is behind it to achieve this?...
15
Mar
Join PMWC 2018 Michigan This June to Learn More about How the Modulation of the Epigenome Increases the Risk for Type 2 Diabetes
Dr. Michael Boehnke (University of Michigan) - who pioneered large-scale studies identifying genetic risk in diabetes and bipolar disorder - shared with us some recent insights about recent advances in exome and genome sequencing and their applications to better understand disease biology and etiology of...
13
Mar
AI and Machine Learning in Healthcare – Not Just Hype Anymore
AI and machine learning has gotten a lot of attention over the last year, as it appears to be poised to become one of the biggest game changer in many industries, including the healthcare sector. ...
